<DOC>
	<DOCNO>NCT01922687</DOCNO>
	<brief_summary>The primary objective study test hypothesis amlodipine plus atorvastatin give single tablet ( Caduet ) , compare amlodipine alone ( Norvasc ) , strong effect protection arterial structure function .</brief_summary>
	<brief_title>Amlodipine Plus/Minus Atorvastatin Protection Arteries</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Amlodipine , atorvastatin drug combination</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Women men , age 40 75 year ; 2 . Women childbearing potential apply adequate nonpharmacological contraceptive technique ; 3 . Untreated patient single antihypertensive drug ( except calcium channel blocker ) uncontrolled blood pressure conventional measurement , range 140 179 mm Hg systolic 90 109 mm Hg diastolic . The conventional blood pressure average 3 consecutive measurement sit position single visit . 4 . The 24 h ambulatory blood pressure least 130 mm Hg systolic 80 mm Hg diastolic , high ; 5 . Fasting total cholesterol concentration range 4.14 6.22 mmol/L ( 160 240 mg/dL ) ; 6 . Endotheliumdependent flowmediated dilatation ( FMD ) 10 % ; 7 . Serum activity aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , creatine kinase ( CK ) within normal range ; 8 . Patients treatment statins lipidlowering drug within 3 month randomization ; 9 . The patient sign inform consent form prior participation trial first visit ; 10 . Patients independent likely adhere study protocol . 1 . Secondary hypertension ; 2 . Lowdensity lipoprotein cholesterol ( LDLC ) 2.59 mmol/L ( 100mg/dL ) ; 3 . Renal dysfunction define eGFR &lt; 60ml/min/1.73m2 ; 4 . Current treatment specific drug diet , fibrates ( especially gemfibrozil ) , verapamil , amiodarone , grapefruit juice ; 5 . Excessive alcohol consumption define drink 1L/day ; 6 . Stroke within 2 year randomization myocardial infarction occur previous ; 7 . Known contraindication dihydropyridine calcium channel blocker statins ; 8 . Any life threatening condition ; 9 . Current participation another trial trial .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>